UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.
NEWS
deCODE Announces Fundamental Discoveries in the Genetics and Pharmacogenomics of Asthma and Allergy
Discoveries will be used to develop novel diagnostic tools and therapies for asthma and allergies, and to optimize patient benefit from existing drugs Reykjavik, ICELAND, July 17, 2002 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) today announced that its scientists...
deCODE Announces Mapping of a Hypertension Gene on Chromosome 18
deCODE study published this month reveals the strongest genetic linkage ever found to the common form of the condition. Reykjavik, ICELAND, June 26, 2002 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) today announced that a team of its scientists has located a gene...
Award by the American Society of Human Genetics
At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.